Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02372651

Ligand	Ligand name	Chain	PDB	Tanimoto
G14	2-phenyl-1H-imidazole-4-carboxylic acid	A,B	3GRJ	0.79
LUM	LUMICHROME	A	2CC6	0.77
LUM	LUMICHROME	A,B	1S4M	0.77
LUM	LUMICHROME	A	2CC7	0.77
LUM	LUMICHROME	A	1HE5	0.77
TRM	1H-BENOXIMIDAZOLE-2-CARBOXYLIC ACID	A	1FQ4	0.71
FTB	N-{4-[1-(2-FLUOROBENZYL)-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL]-PHENYL}-ACETAMIDE	A	1NHX	0.73
4QB	3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID	A	1RWN	0.76
356	8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione	A,B	2RGU	0.71
P6C	2-AMINO-4-ISOPROPYL-PTERIDINE-6-CARBOXYLIC ACID	A,B	1TFM	0.71
P6C	2-AMINO-4-ISOPROPYL-PTERIDINE-6-CARBOXYLIC ACID	A,B	1YF8	0.71
MTX	METHOTREXATE	A,B	1DRB	0.71
MTX	METHOTREXATE	A,B,C,D	2C7V	0.71
MTX	METHOTREXATE	A	1U70	0.71
MTX	METHOTREXATE	A,B,C,D	1MXF	0.71
MTX	METHOTREXATE	A	2QK8	0.71
MTX	METHOTREXATE	A,B	1RB3	0.71
MTX	METHOTREXATE	A,B	1DHJ	0.71
MTX	METHOTREXATE	A	3DAU	0.71
MTX	METHOTREXATE	A	1U72	0.71
MTX	METHOTREXATE	A,B	2DRC	0.71
MTX	METHOTREXATE	A,B	1D1G	0.71
MTX	METHOTREXATE	A,B	1DDR	0.71
MTX	METHOTREXATE	A,B	1E7W	0.71
MTX	METHOTREXATE	A	1RX3	0.71
MTX	METHOTREXATE	A	3DFR	0.71
MTX	METHOTREXATE	A,B,C,D	1P33	0.71
MTX	METHOTREXATE	A	3DAT	0.71
MTX	METHOTREXATE	A,B	1DHI	0.71
MTX	METHOTREXATE	A,B	1TDR	0.71
MTX	METHOTREXATE	A,B	1DRA	0.71
MTX	METHOTREXATE	A	3EIG	0.71
MTX	METHOTREXATE	A	3CD2	0.71
MTX	METHOTREXATE	A	1AO8	0.71
MTX	METHOTREXATE	A	1DF7	0.71
MTX	METHOTREXATE	A	1DLS	0.71
MTX	METHOTREXATE	A	1RG7	0.71
MTX	METHOTREXATE	A	1RH3	0.71
MTX	METHOTREXATE	A,B	4DFR	0.71
MTX	METHOTREXATE	A	1RA3	0.71
MTX	METHOTREXATE	A,B	1DDS	0.71
MTX	METHOTREXATE	A	1DRE	0.71
MTX	METHOTREXATE	A,B	1AXW	0.71
MTX	METHOTREXATE	A	3CL9	0.71
MTX	METHOTREXATE	A,B	3DRC	0.71
MTX	METHOTREXATE	A,B,C,D,E	2OIP	0.71
985	(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid	A	3F2A	0.72
Q2Y	4-OXO-3-[2-(5-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID	A	1RWM	0.7
QUI	2-CARBOXYQUINOXALINE	A	1PFE	0.77
QUI	2-CARBOXYQUINOXALINE	A,B	2DA8	0.77
QUI	2-CARBOXYQUINOXALINE	A,C,E,G	2ADW	0.77
QUI	2-CARBOXYQUINOXALINE	A	1VS2	0.77
QUI	2-CARBOXYQUINOXALINE	A	1XVN	0.77
QUI	2-CARBOXYQUINOXALINE	A,B	185D	0.77
QUI	2-CARBOXYQUINOXALINE	A	1XVK	0.77
QUI	2-CARBOXYQUINOXALINE	A,C	1XVR	0.77
QUI	2-CARBOXYQUINOXALINE	A,B	3GO3	0.77
OQB	4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID	A	1RWW	0.76
NFL	2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID	A	1TD7	0.74
FOL	FOLIC ACID	A	1PJ6	0.73
FOL	FOLIC ACID	A,B	1RD7	0.73
FOL	FOLIC ACID	A,B	1DHF	0.73
FOL	FOLIC ACID	A,B,C,D,E	1QZF	0.73
FOL	FOLIC ACID	A	4CD2	0.73
FOL	FOLIC ACID	A	1RX7	0.73
FOL	FOLIC ACID	A	1RX2	0.73
FOL	FOLIC ACID	A	1RX8	0.73
FOL	FOLIC ACID	A	1RA2	0.73
FOL	FOLIC ACID	A,B	1RE7	0.73
FOL	FOLIC ACID	A	7DFR	0.73
FOL	FOLIC ACID	A	1VIF	0.73
FOL	FOLIC ACID	A,B	1RB2	0.73
FOL	FOLIC ACID	A	1CD2	0.73
FOL	FOLIC ACID	A	2CD2	0.73
FOL	FOLIC ACID	A,B	1DYI	0.73
FOL	FOLIC ACID	A	1DRF	0.73
FOL	FOLIC ACID	A,B,C,D	3BMC	0.73
FOL	FOLIC ACID	A,B	2D0K	0.73
FOL	FOLIC ACID	A	1RA8	0.73
CY0	S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE	A	2J5E	0.73
RBS	N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE	A,B	2HWO	0.71
THH	N-[4-({[(6S)-2-AMINO-4-HYDROXY-5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID	A,B	3DCJ	0.7
THH	N-[4-({[(6S)-2-AMINO-4-HYDROXY-5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID	A,B	1WSV	0.7
PT1	PTEROIC ACID	A,B	1TX0	0.71
PT1	PTEROIC ACID	A	1BR6	0.71
PT1	PTEROIC ACID	A,B	1HWP	0.71
TSX	N-[4-(1-ALLYL-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL)-PHENYL]-ACETAMIDE	A	1M51	0.7
P5C	2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide	A	3FQE	0.71